M. Hosseinipour, Felicia Ekpo, Nwanneka Okwundu, Monica Huynh, S. Zarkhin, D. Papadopoulos, C. Hoffman
{"title":"Use of Triamcinolone to Reduce the Inflammation Associated with Kybella Injection","authors":"M. Hosseinipour, Felicia Ekpo, Nwanneka Okwundu, Monica Huynh, S. Zarkhin, D. Papadopoulos, C. Hoffman","doi":"10.15226/2378-1726/7/1/001108","DOIUrl":null,"url":null,"abstract":"Background: Submental fullness has been a concern for patients in dermatology for years. Liposuction and cosmetic surgery were considered the mainstay for elimination of unwanted submental fat. However, these procedures are invasive and associated with major complications like prolonged recovery times, and the risk of contour irregularities. In 2015, Kybella (deoxycholic acid) was approved as a first-in-class injectable agent for the treatment of submental fullness. Although, it is non-invasive and has less complications than plastic surgery, it is still associated with adverse effects such as pain, swelling/edema, and bruising. The most concerning adverse effect for patients is the prolonged inflammation that may occur for up to 2 weeks post-injection. Objective: This is a comparison trial of deoxycholic acid injections with or without triamcinolone acetate for the reduction of submental fat in one patient. The study will also assess the effect of triamcinolone acetate on post-injection inflammation associated with deoxycholic acid injection in the treatment of submental fullness. Method: A 35-year-old female presented for evaluation of submental fullness and opted for treatment with Kybella. Her right submental treatment area was injected with 2ml of deoxycholic acid 10mg/ml plus 0.2ml triamcinolone acetate. The left submental treatment area was treated with 2ml of deoxycholic acid 10mg/ ml alone. The patient was observed over a duration of 3 months to evaluate inflammation and treatment response between the two treatment zones. Results: This split-neck study resulted in decreased postinjection swelling. However, at 3-month follow-up, there was no clinical improvement to the submental fullness bilaterally. Limitations: Small sample size, lack of objective measures, possible diffusion between treatment zones, and prior deoxycholic acid treatment. Conclusion: Triamcinolone can decrease post-injection swelling if given as an adjunct to Kybella treatment.","PeriodicalId":15586,"journal":{"name":"Journal of Clinical Research","volume":"43 1","pages":"1-4"},"PeriodicalIF":0.0000,"publicationDate":"2020-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.15226/2378-1726/7/1/001108","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Submental fullness has been a concern for patients in dermatology for years. Liposuction and cosmetic surgery were considered the mainstay for elimination of unwanted submental fat. However, these procedures are invasive and associated with major complications like prolonged recovery times, and the risk of contour irregularities. In 2015, Kybella (deoxycholic acid) was approved as a first-in-class injectable agent for the treatment of submental fullness. Although, it is non-invasive and has less complications than plastic surgery, it is still associated with adverse effects such as pain, swelling/edema, and bruising. The most concerning adverse effect for patients is the prolonged inflammation that may occur for up to 2 weeks post-injection. Objective: This is a comparison trial of deoxycholic acid injections with or without triamcinolone acetate for the reduction of submental fat in one patient. The study will also assess the effect of triamcinolone acetate on post-injection inflammation associated with deoxycholic acid injection in the treatment of submental fullness. Method: A 35-year-old female presented for evaluation of submental fullness and opted for treatment with Kybella. Her right submental treatment area was injected with 2ml of deoxycholic acid 10mg/ml plus 0.2ml triamcinolone acetate. The left submental treatment area was treated with 2ml of deoxycholic acid 10mg/ ml alone. The patient was observed over a duration of 3 months to evaluate inflammation and treatment response between the two treatment zones. Results: This split-neck study resulted in decreased postinjection swelling. However, at 3-month follow-up, there was no clinical improvement to the submental fullness bilaterally. Limitations: Small sample size, lack of objective measures, possible diffusion between treatment zones, and prior deoxycholic acid treatment. Conclusion: Triamcinolone can decrease post-injection swelling if given as an adjunct to Kybella treatment.
背景:多年来,精神下充盈一直是皮肤科患者关注的问题。抽脂和整容手术被认为是消除多余的颏下脂肪的主要方法。然而,这些手术是侵入性的,并伴有主要并发症,如延长恢复时间和轮廓不规则的风险。2015年,Kybella(脱氧胆酸)被批准为治疗精神饱满的一流注射药物。尽管与整形手术相比,它是非侵入性的,并发症也更少,但它仍然会带来诸如疼痛、肿胀/水肿和瘀伤等副作用。患者最担心的不良反应是注射后长达2周的长期炎症。目的:这是一项比较试验,脱氧胆酸注射加或不加醋酸曲安奈德,以减少一名患者的颏下脂肪。该研究还将评估醋酸曲安奈德对注射去氧胆酸治疗精神饱满的注射后炎症的影响。方法:一位35岁的女性提出了评估心理下丰满度,并选择了Kybella治疗。右侧脑下治疗区注射脱氧胆酸10mg/ml 2ml加醋酸曲安奈德0.2ml。左脑下治疗区单独给予脱氧胆酸10mg/ ml 2ml。对患者进行为期3个月的观察,以评估两个治疗区之间的炎症和治疗反应。结果:该裂颈研究减少了注射后肿胀。然而,在3个月的随访中,双侧的颏下充盈没有临床改善。局限性:样本量小,缺乏客观测量,治疗区之间可能扩散,既往脱氧胆酸治疗。结论:曲安奈德配合Kybella治疗可减少注射后肿胀。